ResMed Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
RMD New York 3840 www.resmed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ResMed Inc.

ResMed (RMD) Acquires Noctrix Health to Expand Sleep Disorder Portfolio - Jun 5th, 2026 3:24 pm
ResMed completes $340m Noctrix Health acquisition - Jun 4th, 2026 5:17 am
3 Big Reasons RMD Should Be On Your Watchlist - Jun 3rd, 2026 11:43 am
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide? - Jun 3rd, 2026 6:14 am
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million - Jun 3rd, 2026 5:40 am
Resmed completes $340M Noctrix takeover - Jun 2nd, 2026 12:30 am
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio - Jun 1st, 2026 2:05 pm
Do Wall Street Analysts Like ResMed Stock? - May 25th, 2026 4:35 am
2 Healthcare Stocks to Research Further and 1 We Find Risky - May 23rd, 2026 5:08 am
3 Large-Cap Stocks to Consider Right Now - May 22nd, 2026 1:48 pm
How Investors Are Reacting To ResMed (RMD) Linking Oura Ring Wearables To Clinical Sleep Care - May 20th, 2026 3:14 pm
Is the Options Market Predicting a Spike in ResMed Stock? - May 20th, 2026 12:36 pm
ResMed (RMD) Valuation Check As Oura Sleep Health Collaboration Aims To Expand Sleep Apnea Care Access - May 20th, 2026 3:13 am
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference - May 19th, 2026 2:05 pm
Silver Economy Investing: Why the Healthcare Giants Are in Focus - May 19th, 2026 1:00 pm
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care - May 19th, 2026 7:00 am
Jim Cramer Discusses the Performance of Danaher and Its Peers - May 14th, 2026 9:40 am
ResMed (NYSE:RMD) Could Be A Buy For Its Upcoming Dividend - May 9th, 2026 7:15 am
Why ResMed (RMD) Narrative Is Shifting As Analysts Reassess Growth And Valuation Assumptions - May 3rd, 2026 6:06 am
2 Cash-Heavy Stocks with Exciting Potential and 1 We Turn Down - May 2nd, 2026 11:48 am